These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34994112)

  • 21. Recent advances in photodynamic therapy for cancer and infectious diseases.
    Shi X; Zhang CY; Gao J; Wang Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Sep; 11(5):e1560. PubMed ID: 31058443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nano based drug delivery systems: recent developments and future prospects.
    Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
    J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nano-therapeutics: A revolution in infection control in post antibiotic era.
    Zaidi S; Misba L; Khan AU
    Nanomedicine; 2017 Oct; 13(7):2281-2301. PubMed ID: 28673854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction-responsive polymers for drug delivery in cancer therapy-Is there anything new to discover?
    Monteiro PF; Travanut A; Conte C; Alexander C
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Mar; 13(2):e1678. PubMed ID: 33155421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in engineering local drug delivery systems for cancer immunotherapy.
    Abdou P; Wang Z; Chen Q; Chan A; Zhou DR; Gunadhi V; Gu Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1632. PubMed ID: 32255276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology.
    Xue X; Liang XJ
    Chin J Cancer; 2012 Feb; 31(2):100-9. PubMed ID: 22237039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies targeting tumor immune and stromal microenvironment and their clinical relevance.
    Hu M; Huang L
    Adv Drug Deliv Rev; 2022 Apr; 183():114137. PubMed ID: 35143893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
    Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
    Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
    Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
    J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integration of target discovery, drug discovery and drug delivery: A review on computational strategies.
    Duarte Y; Márquez-Miranda V; Miossec MJ; González-Nilo F
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1554. PubMed ID: 30932351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacteria and Archaea: A new era of cancer therapy.
    Moghimipour E; Abedishirehjin S; Baghbadorani MA; Handali S
    J Control Release; 2021 Oct; 338():1-7. PubMed ID: 34391833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.
    Huh AJ; Kwon YJ
    J Control Release; 2011 Dec; 156(2):128-45. PubMed ID: 21763369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanomedicines for combating multidrug resistance of cancer.
    Zhu YX; Jia HR; Duan QY; Wu FG
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1715. PubMed ID: 33860622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimuli-activatable nanomedicines for chemodynamic therapy of cancer.
    Wang W; Jin Y; Xu Z; Liu X; Bajwa SZ; Khan WS; Yu H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1614. PubMed ID: 32011108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liposomes as Antibiotic Delivery Systems: A Promising Nanotechnological Strategy against Antimicrobial Resistance.
    Ferreira M; Ogren M; Dias JNR; Silva M; Gil S; Tavares L; Aires-da-Silva F; Gaspar MM; Aguiar SI
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33918529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomimetic Nanotechnology toward Personalized Vaccines.
    Zhou J; Kroll AV; Holay M; Fang RH; Zhang L
    Adv Mater; 2020 Apr; 32(13):e1901255. PubMed ID: 31206841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanomedicine-based strategies to target and modulate the tumor microenvironment.
    Mendes BB; Sousa DP; Conniot J; Conde J
    Trends Cancer; 2021 Sep; 7(9):847-862. PubMed ID: 34090865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant glycosylation patterns on cancer cells: Therapeutic opportunities for glycodendrimers/metallodendrimers oncology.
    Moffett S; Shiao TC; Mousavifar L; Mignani S; Roy R
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1659. PubMed ID: 32776710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging nanomedicine-based strategies for preventing metastasis of pancreatic cancer.
    Li YJ; Wu JY; Wang JM; Xiang DX
    J Control Release; 2020 Apr; 320():105-111. PubMed ID: 31978441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.